Systemic Glycosaminoglycan Clearance by HARE/Stabilin-2 Activates Intracellular Signaling.

The role of scavenger receptors in maintaining physiological balance remains an active area of investigation. Prior research has shown that these receptors are involved in the removal of a wide range of molecules from bodily fluids. However, the specific mechanisms by which they contribute to intracellular signaling are not fully understood. No prior work had resolved how glycosaminoglycan clearance might influence downstream signaling events. This gap motivated a closer examination of the HARE/Stab2 receptor system. The broader field has established the importance of endocytosis in immune and metabolic regulation. Yet, the signaling consequences of HARE-mediated GAG uptake remain unclear. This uncertainty drives the need for a focused review of the available evidence. The current literature offers a foundation for understanding the functional diversity of scavenger receptors.

This review aims to clarify the role of HARE in intracellular signaling triggered by glycosaminoglycan clearance. The specific problem lies in the incomplete understanding of how receptor-mediated endocytosis influences downstream pathways. The motivation stems from the need to connect GAG clearance with signaling outcomes. The authors seek to synthesize findings on the Extracellular Signal-Regulated Kinase 1/2 pathway. They focus on the distinction between full-length Stab2 and HARE functions. The goal is to highlight how HARE differs from Stab2 in ligand binding and signaling. The study also seeks to identify the range of GAGs that activate HARE. This work contributes to the broader understanding of scavenger receptor signaling.

The authors employed a literature review approach to analyze published findings on HARE and Stab2. They synthesized data from multiple studies on ligand binding and receptor function. The review includes findings on the seven identified GAG ligands for HARE. The authors examined the timeline of HA as the first identified ligand. They also assessed the structural differences between HARE and Stab2. The review approach focused on signaling activation during endocytosis. The authors compared phagocytic and endocytic functions of the two receptor forms. They evaluated the role of HARE in the ERK1/2 pathway activation.

HARE mediates endocytosis of all known soluble ligands, including seven GAGs and dextran sulfate. The first identified ligand was hyaluronic acid in 1981. HARE signaling was first observed in 2008 during HA endocytosis. The ERK1/2 pathway is a key signaling outcome of HARE activation. Not all ligands trigger intracellular signaling through HARE. Full-length Stab2 is involved in phagocytosis but not in GAG signaling. HARE is the C-terminal half of Stab2 and lacks phagocytic function. The review highlights the distinct roles of the two receptor isoforms in signaling.

The authors propose that HARE-mediated GAG clearance activates intracellular signaling pathways. The ERK1/2 pathway is a primary target of this signaling. The review suggests that not all ligands induce signaling through HARE. The distinction between HARE and Stab2 functions is critical. The authors note that full-length Stab2 does not activate the same pathways. The review supports the idea that GAG clearance is functionally distinct from phagocytosis. The findings suggest a need for further investigation into HARE signaling diversity. The authors emphasize the importance of understanding receptor isoform-specific functions.